Pharmaceuticals

Understanding the M&A Landscape: Q&A with Cheryl Reisin

bexib
By bexib 0 Min Read

As the second half of 2024 begins, industry experts discuss mergers and acquisitions trends in the pharmaceutical industry.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article This Labor Day, working families’ earned Social Security benefits are at risk.
Next Article Link September 3, 2024 | Naked Capitalism
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

From Porsche to Purpose: A CMO’s Journey
Retail & E-commerce
Upskilling: An interview with Steph Piper
Manufacturing
Young Kiwis toast change: hazardous drinking falls by 13% in five years
Hospitality & Tourism
Clearview FCU saves 6,000 labor hours through RPA
Banking